teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - la esclerosis múltiple remitente-recurrente - inmunosupresores - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - la esclerosis múltiple remitente-recurrente - los inmunosupresores selectivos de inmunosupresores - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - preparaciones antianémicas - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.
leflunomida aurovitas 10 mg comprimidos recubiertos con pelicula efg
aurovitas spain, s.a.u. - leflunomida - comprimido recubierto con pelÍcula - 10 mg - leflunomida 10 mg - leflunomida
leflunomida aurovitas 20 mg comprimidos recubiertos con pelicula efg
aurovitas spain, s.a.u. - leflunomida - comprimido recubierto con pelÍcula - 20 mg - leflunomida 20 mg - leflunomida
lapatinib stada 250 mg comprimidos recubiertos con pelicula efg
laboratorio stada s.l. - lapatinib - comprimido recubierto con pelÍcula - 250 mg - lapatinib 250 mg - lapatinib
tecanex 4mg polvo para concentrado para solucion para perfusion
suiza medical import s.a.c. - polvo para concentrado para solucion para perfusion - por vial 4.00 mg - topotecán
vegzelma 100 mg/ 4 ml concentrado para solucion para perfusion
celltrion healthcare peru s.a.c. - droguerÍa - bevacizumab - concentrado para solucion para perfusion - 100 mg/ 4 ml - por vial 4.00 ml - - bevacizumab
vegzelma 400 mg/ 16 ml concentrado para solucion para perfusion
celltrion healthcare peru s.a.c. - droguerÍa - bevacizumab - concentrado para solucion para perfusion - 400 mg/ 16 ml - por vial 16.00 ml - - bevacizumab
avastin 25 mg/ml 1 vial 4 ml